Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Mod GRF 1-29

Sermorelin, Growth Hormone Releasing Hormone (1-29), hGRF(1-29)NH2

Quick Stats
Studies 227
Trials 47
Score 1
1987 pubmed

Growth hormone, somatomedin levels and growth regulation in Turner's syndrome.

Ranke. M B MB; Blum. W F WF; Haug. F F; Rosendahl. W W; Attanasio. A A; Enders. H H; Gupta. D D; Bierich. J R JR

Key Findings

  • GH responses to GRF (1-29) and arginine were within normal ranges in Turner syndrome patients.
  • Somatomedin (IGF) bioactivity was higher than normal before bone age 10, then fell to low‑normal or below normal later.
  • Spontaneous GH secretion during deep sleep declined with age and did not show the usual puberty‑related rise.

Practical Outcomes

  • For most biohackers, the results have limited direct use because they apply to a specific medical condition. The data suggest that GH‑releasing peptide 1‑29 works normally in this group, but overall GH dynamics are influenced by sex hormones, so any self‑experimentation with GRF‑1‑29 should consider hormonal status and individual variability.

Summary

The study looked at growth hormone (GH) and related proteins in girls with Turner syndrome, a rare genetic condition. It found that the basic GH system works normally, but the levels change over time because these girls lack normal ovarian hormones. Some individuals may still have unusually low GH or IGF levels.

Abstract

In a total of 56 children and adolescents with Turner's syndrome (41 with karyotype 45,X) basal serum levels of somatomedin bioactivity, Sm-C/IGF-I (RIA), IGF II (RIA), GH response to arginine and GHRH (GRF(1-29)NH2), and spontaneous GH secretion during 5.5 h of deep sleep were determined in a cross-sectional manner. GH responses to GRF and arginine as well as IGF-II levels were found to be in the normal range. Levels of somatomedin bioactivity were higher than normal before a bone age of 10 years, in the low-normal range thereafter, and below normal in some patients. Levels of Sm-C/IGF-I were found normal before and low-normal after a bone age of ten years. There was a trend towards increasing Sm-C/IGF-I levels with age. In contrast to the normal pattern, spontaneous sleep-related GH secretion was declining with age and did not show the puberty-associated rise. These findings suggest a normally functioning growth hormone-somatomedin axis in Turner's syndrome with alterations of its functioning level occurring secondarily as a result of absent gonadal activation. In single patients abnormally low growth hormone and/or somatomedin secretion may be present.

Study Information

Provider

pubmed

Year

1987

DOI

10.1530/acta.0.1160305